Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Depleting TMED3 alleviates the development of endometrial carcinoma

Fig. 5

TMED3 knockdown limits tumor growth in vivo. A The comparison in tumor volume between mouse models of shCtrl and shTMED3 groups after injected ishikawa cells. B The bioluminescence images of the experimental mice and the comparison in the total bioluminescence intensity of mouse models (shCtrl vs. shTMED3). C The photo of removed solid tumors from experimental mice and the difference in the tumor weight between shCtrl and shTMED3 groups. D Pathological images of the solid tumors after TMED3 staining in shCtrl and shTMED3 groups. E Pathological images of the solid tumors after Ki-67 staining in shCtrl and shTMED3 groups. The scale bar is 50 μm long. ***P < 0.001

Back to article page